SRPK2 inhibition could potentially re-sensitise CRPC to ADT through the reduction in AR-V7, however, the roles of SRPK2 and DYRK3 in PCa and splicing of the AR requires further investigation. The gene discussed is AR; the disease is posterior cortical atrophy.